Guardant Health has filed a lawsuit against rival Natera in California federal court, alleging that former employees stole thousands of confidential files to aid Natera’s development of competing cancer-detection blood tests. The lawsuit follows a previous $292.5 million false advertising verdict against Natera in November. Guardant claims its Shield test was the first FDA-approved early cancer blood test and accuses Natera of aggressively recruiting its employees to gain a competitive edge. Guardant seeks an injunction and monetary damages, while Natera denies the allegations, calling them baseless.
Keep Reading
Add A Comment